Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir

BACKGROUND: This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX. METHODS: This study was an open labeled pharmacokinetic study in twelve HIV-serone...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Acquir Immune Defic Syndr
Autori principali: Bruce, R. Douglas, Altice, Frederick L., Moody, David E., Morse, Gene D., Andrews, Laurie, Lin, Shen-Nan, Fang, Wenfang B., Ma, Qing, Friedland, Gerald H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4841260/
https://ncbi.nlm.nih.gov/pubmed/20672450
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi